CLASSIFICATION OF VASCULAR SMOOTH MUSCLE ALPHA-RECEPTORS

血管平滑肌 α 受体的分类

基本信息

项目摘要

Several drugs that are used clinically in the treatment of cardiovascular disease act at the vascular alpha1-adrenoceptors. It is important, especially from the stand-point of drug design, to classify and characterize these receptors. This proposal is directed toward this goal and will lead to a greater understanding of the molecular events involved in drug action. On the basis of current pharmacological evidence, it is proposed that vascular alpha1-adrenoceptors exhibit species, tissue and blood vessel heterogeneity. Since the classification of receptors will ultimately involve a knowledge of their pharmacological properties and receptor structure the hypothesis will be explored using these two criteria. The affinities of a series of alpha-adrenergic ligands for alpha1- adrenoceptors will be determined in rat and rabbit arteries in radioligand binding experiments. Evidence for alpha1- adrenoceptor heterogeneity will come from differences in ligand affinities with regard to rank order of potency and/or absolute values. Since variations in the receptors' microenvironment are known to affect the binding and intrinsic activities of both agonists and antagonists, the affinities of the ligands will be determined in broken cell membrane and detergent solubilized receptor preparations as well as in the presence of known receptor modulators. The hypothesis will be supported if it is found that ligands retain their discriminating actions under these conditions. Secondly, it may be possible to distinguish between subpopulations of alpha1-adrenoceptors on the basis of certain gross molecular parameters such as their molecular size, isoelectric points, hydrodynamic properties and glycoprotein nature. This proposal is directed toward the long-term objectives of classifying and fully characterizing vascular receptors and will form the basis for the arduous task of receptor purification.
几种临床上用于治疗慢性阻塞性肺疾病的药物 心血管疾病作用于血管α1-肾上腺素受体。 重要的是,尤其是从药物设计的角度来看, 对这些受体进行分类和表征。这项建议是 朝向这一目标,并将导致更多的理解 与药物作用有关的分子事件。 在现有药理证据的基础上,建议 血管α1肾上腺素受体展示了物种、组织和 血管异质性。由于受体的分类 最终将涉及到对其药理作用的了解 性质和受体结构这一假设将被探索 使用这两个标准。 一系列α-肾上腺素能配体与α-1-的亲和力 将测定大鼠和兔动脉的肾上腺素能受体。 放射性配基结合实验。字母1的证据- 肾上腺素受体的异质性将来自配基的差异 关于效力和/或绝对等级顺序的亲和度 价值观。因为受体微环境的变化是 已知会影响两者的结合和内在活性 激动剂和拮抗剂,配体的亲和力将是 在破碎的细胞膜和溶解的洗涤剂中测定 受体制剂以及在已知 受体调节剂。如果是这样的话,这一假设就会得到支持 发现配体在这些条件下保留了它们的区别作用 条件。 其次,有可能区分不同的亚群 基于某些粗大分子的α1-肾上腺素能受体 它们的分子大小、等电点、 流体力学性质和糖蛋白性质。 这项建议是针对以下长期目标的 对血管受体和意志进行分类和充分表征 为艰巨的受体纯化任务奠定了基础。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Identification of the alpha 1c-adrenoceptor in rabbit arteries and the human saphenous vein using the polymerase chain reaction.
使用聚合酶链式反应鉴定兔动脉和人隐静脉中的 α1c-肾上腺素受体。
  • DOI:
    10.1016/0922-4106(94)90064-7
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Diehl,NL;Shreeve,SM
  • 通讯作者:
    Shreeve,SM
Classification of bovine aortic alpha-1 adrenoceptors by the criteria of ligand affinity and molecular mass.
根据配体亲和力和分子质量标准对牛主动脉 α-1 肾上腺素受体进行分类。
Molecular properties of the vasoactive intestinal peptide receptor in aorta and other tissues.
主动脉和其他组织中血管活性肠肽受体的分子特性。
  • DOI:
    10.1016/0196-9781(92)90050-d
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    3
  • 作者:
    Shreeve,SM;DeLuca,AW;Diehl,NL;Kermode,JC
  • 通讯作者:
    Kermode,JC
Reconstitution of alpha 1-adrenoceptors having high affinity for prazosin.
重建对哌唑嗪具有高亲和力的 α1-肾上腺素受体。
  • DOI:
    10.1016/0922-4106(92)90061-y
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Valliere,JE;DeLuca,AW;Shreeve,SM
  • 通讯作者:
    Shreeve,SM
The alpha 1-adrenoceptor is inactivated by alterations in membrane phospholipids.
α1-肾上腺素受体因膜磷脂的改变而失活。
  • DOI:
    10.1016/0922-4106(92)90079-b
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Shreeve,SM;Valliere,JE
  • 通讯作者:
    Valliere,JE
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEPHEN M SHREEVE其他文献

STEPHEN M SHREEVE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEPHEN M SHREEVE', 18)}}的其他基金

CLASSIFICATION OF VASCULAR SMOOTH MUSCLE ALPHA-RECEPTORS
血管平滑肌 α 受体的分类
  • 批准号:
    3471348
  • 财政年份:
    1987
  • 资助金额:
    $ 11.14万
  • 项目类别:
CLASSIFICATION OF VASCULAR SMOOTH MUSCLE ALPHA-RECEPTORS
血管平滑肌 α 受体的分类
  • 批准号:
    3471350
  • 财政年份:
    1987
  • 资助金额:
    $ 11.14万
  • 项目类别:
CLASSIFICATION OF VASCULAR SMOOTH MUSCLE ALPHA-RECEPTORS
血管平滑肌 α 受体的分类
  • 批准号:
    3471347
  • 财政年份:
    1987
  • 资助金额:
    $ 11.14万
  • 项目类别:
CLASSIFICATION OF VASCULAR SMOOTH MUSCLE ALPHA-RECEPTORS
血管平滑肌 α 受体的分类
  • 批准号:
    3471349
  • 财政年份:
    1987
  • 资助金额:
    $ 11.14万
  • 项目类别:
MOLECULAR CLONING & EXPRESSION OF CDNA FOR RABBIT CARDIAC X1 ADRENOCEPTOR
分子克隆
  • 批准号:
    3869001
  • 财政年份:
  • 资助金额:
    $ 11.14万
  • 项目类别:

相似海外基金

MRI: Acquisition of an X-ray Diffractometer for Research and Training in Chemical Structure-Function Studies
MRI:购买 X 射线衍射仪用于化学结构-功能研究的研究和培训
  • 批准号:
    1726630
  • 财政年份:
    2017
  • 资助金额:
    $ 11.14万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了